Production (Stage)
Amphastar Pharmaceuticals, Inc.
AMPH
$24.47
$0.271.12%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 25.29M | 37.96M | 40.43M | 37.95M | 43.18M |
| Total Depreciation and Amortization | 15.21M | 14.66M | 14.43M | 14.15M | 13.96M |
| Total Amortization of Deferred Charges | 762.00K | 724.00K | 744.00K | 2.44M | 2.13M |
| Total Other Non-Cash Items | 10.54M | -15.74M | 11.68M | 5.94M | 3.29M |
| Change in Net Operating Assets | -16.71M | -8.59M | -7.33M | 8.64M | -7.27M |
| Cash from Operations | 35.08M | 29.02M | 59.96M | 69.11M | 55.29M |
| Capital Expenditure | -10.70M | -12.41M | -13.79M | -6.04M | -8.79M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | 0.00 | 0.00 | -129.00M | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.18M | -23.27M | -20.79M | 65.14M | 24.03M |
| Cash from Investing | 10.48M | -35.68M | -34.59M | -69.90M | 15.24M |
| Total Debt Issued | 1.64M | 4.87M | 9.51M | -25.00K | 4.08M |
| Total Debt Repaid | -38.00K | -115.00K | -41.00K | -8.01M | -98.00K |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -15.69M | -38.62M | -31.70M | -2.68M | -17.31M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -422.00K | 22.00K | -587.00K | 1.00K | -252.00K |
| Cash from Financing | -14.50M | -33.84M | -22.82M | -10.72M | -13.58M |
| Foreign Exchange rate Adjustments | 118.00K | -11.00K | -63.00K | -19.00K | -97.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 31.17M | -40.51M | 2.50M | -11.53M | 56.85M |